Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 1.721
+0.021 (1.24%)
Aug 15, 2025, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 561.99 million as of August 15, 2025. Its market cap has decreased by -88.54% in one year.
Market Cap
561.99M
Enterprise Value
-521.10M
Revenue
87.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.72
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 561.99M, a decrease of -89.83%. That is a compound annual growth rate of -33.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 561.99M | -43.50% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.16B |
| Nordhealth AS | 2.77B |
| Photocure ASA | 1.65B |
| ArcticZymes Technologies ASA | 1.35B |
| Vistin Pharma ASA | 1.08B |
| Omda AS | 1.02B |
| Thor Medical ASA | 917.76M |
| Gentian Diagnostics ASA | 891.41M |